Ulcerative Colitis
|
0.410 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.
|
28067908 |
2017 |
Ulcerative Colitis
|
0.410 |
GeneticVariation
|
disease |
GWASCAT |
Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci.
|
26974007 |
2016 |
Ulcerative Colitis
|
0.410 |
GeneticVariation
|
disease |
GWASCAT |
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.
|
26192919 |
2015 |
Ulcerative Colitis
|
0.410 |
GeneticVariation
|
disease |
GWASCAT |
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
|
23128233 |
2012 |
Ulcerative Colitis
|
0.410 |
GeneticVariation
|
disease |
GWASDB |
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
|
23128233 |
2012 |
Ulcerative Colitis
|
0.410 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.
|
21297633 |
2011 |
Ulcerative Colitis
|
0.410 |
Biomarker
|
disease |
BEFREE |
Genetic evidence has also demonstrated the importance of barrier function to the development of ulcerative colitis (HNF4A, LAMB1, CDH1 and GNA12).
|
21300624 |
2011 |
Ulcerative Colitis
|
0.410 |
GeneticVariation
|
disease |
GWASDB |
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.
|
21297633 |
2011 |
Ulcerative Colitis
|
0.410 |
Biomarker
|
disease |
CTD_human |
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.
|
21297633 |
2011 |
Psychotic Disorders
|
0.300 |
Biomarker
|
group |
PSYGENET |
Olanzapine-induced methylation alters cadherin gene families and associated pathways implicated in psychosis.
|
25266742 |
2014 |
Nonorganic psychosis
|
0.300 |
Biomarker
|
disease |
PSYGENET |
Olanzapine-induced methylation alters cadherin gene families and associated pathways implicated in psychosis.
|
25266742 |
2014 |
Myocardial Ischemia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Cardioplegia prevents ischemia-induced transcriptional alterations of cytoprotective genes in rat hearts: a DNA microarray study.
|
16214533 |
2005 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic analyses of diverse populations improves discovery for complex traits.
|
31217584 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Gastroenteropancreatic neuroendocrine tumours (GEP NET) are a heterogeneous group of rare tumours that have distinct effects on the body due to their tumour location and potential to secrete hormones and peptides.
|
31550712 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
GEP-NET primary tumor location or secretory syndrome did not influence the risk for MetS.
|
31533348 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Immunotherapy might be a promising therapeutic approach in GEP-NENs especially in tumors with high TILs.
|
30608901 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The results included the identification of 70% of SLN-negative patients who experienced metastasis as Class 2, the discovery of reduced recurrence-free survival for patients with thin tumors and Class 2B biology compared with that of those with Class 1A biology (P < .0001); and determination of the 31-GEP test as an independent predictor of risk compared with traditional staging factors in patients with stage I to IIA tumors.
|
30081113 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Effect of RMP on tumor progression in nude mouse models was assessed by measurement of volume and weight of tumors.
|
31333787 |
2019 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Herein, we studied whether primary tumor site affects survival in patients with GEP-NETs and liver metastases (NELM).
|
30992703 |
2019 |
Neuroendocrine Tumors
|
0.100 |
GeneticVariation
|
group |
BEFREE |
We analyzed the relationship between metabolic syndrome and histological, epidemiological, and prognosis variables in two cohorts of patients with neuroendocrine tumors (NETs): those with lung carcinoids (LCs; n = 81) and those with gastroenteropancreatic NET (GEP-NET; n = 100).
|
30265346 |
2019 |
Neuroendocrine Tumors
|
0.100 |
Biomarker
|
group |
BEFREE |
An association of well-differentiated gastroenteropancreatic neuroendocrine tumours (WD GEP NETs) with metabolic syndrome (MetS) was recently described.
|
31466863 |
2019 |
Body Fat Distribution
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study of body fat distribution identifies adiposity loci and sex-specific genetic effects.
|
30664634 |
2019 |
Lean body mass
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomics of body fat percentage may contribute to sex bias in anorexia nervosa.
|
30593698 |
2019 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
RMP might play an important role in defects of apoptosis, hence the chemotherapeutic resistance in hepatocellular carcinoma.
|
31754340 |
2019 |